TTNP TITAN PHARMACEUTICALS INC

Nasdaq titanpharm.com


$ 5.97 $ -0.18 (-3.76 %)    

Wednesday, 01-Oct-2025 19:57:28 EDT
QQQ $ 602.76 $ 5.20 (0.87 %)
DIA $ 461.59 $ 2.15 (0.47 %)
SPY $ 662.99 $ 3.52 (0.53 %)
TLT $ 91.15 $ -0.08 (-0.09 %)
GLD $ 388.23 $ -8.98 (-2.26 %)
$ 4.61
$ 4.71
$ 5.80 x 2
$ 5.94 x 1
-- - --
$ 3.03 - $ 5.76
3,358,220
na
6.13M
$ 0.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-20-2025 12-31-2024 10-K
4 01-03-2025 09-30-2024 10-Q
5 08-15-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 04-01-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-31-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-25-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-15-2020 03-31-2020 10-Q
23 03-30-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 04-01-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 04-02-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-16-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 titan-pharmaceuticals-stock-surges-23-after-hours-on-stockholder-approval-of-three-way-merger

Titan Pharmaceuticals shares jumped 23% after stockholders approved a three-way merger with Black Titan and TalenTec.

 us-stocks-likely-to-open-higher-expert-says-the-selling-pressure-is-starting-to-be-exhausted

U.S. stock futures rose on Monday following Friday's advances. Futures of major benchmark indices were higher in premarket.

 titan-pharmaceuticals-gets-non-compliance-notice-from-nasdaq

Under Nasdaq rules, the Company has 60 calendar days from receipt of the 5250 Notice or until January 21, 2025, to submit a pla...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION